e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?
Camus Philippe, von der Thüsen Jan, Hansell David M., Colby Thomas V.
Source:
Eur Respir J 2014; 44: 289-296
Journal Issue:
August
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Camus Philippe, von der Thüsen Jan, Hansell David M., Colby Thomas V.. Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?. Eur Respir J 2014; 44: 289-296
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Source: International Congress 2017 – ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Year: 2017
ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Source: Milan 2017 - Educational material
Year: 2017
Pleuroparenchymal fibroelastosis: report of 4 cases
Source: International Congress 2017 – Rare diseases
Year: 2017
Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?
Source: Eur Respir J 2015; 45: 1183-1186
Year: 2015
Pleuroparenchymal fibroelastosis - clinical analysis of 22 cases
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
Source: Eur Respir J 2012; 40: 377-385
Year: 2012
Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?
Source: Eur Respir J 2013; 41: 243-245
Year: 2013
The health status in idiopathic pleuroparenchymal fibroelastosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Case 2: Is it left ventricular dysfunction or PAH?
Source: International Congress 2017 – CC6 Is it truly pulmonary arterial hypertension?
Year: 2017
Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents
Source: Eur Respir J 2014; 44: 523-527
Year: 2014
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Architectural remodelling in idiopathic interstitial pneumonias: fibrosis or fibroelastosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004
Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015
The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis
Source: Eur Respir Rev 2014; 23:263-266
Year: 2014
Severe pulmonary hypertension: walking through new paths to revisit an old field
Source: Eur Respir J 2002; 20: 509-510
Year: 2002
Exercise training in idiopathic pulmonary fibrosis: is it of benefit?
Source: Breathe 2016; 12: 130-138
Year: 2016
Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction?
Source: Eur Respir Rev 2009; 19: 4-6
Year: 2010
Lost in translation: Does radiological evidence of right ventricular strain in acute pulmonary embolism trigger echocardiographic follow-up?
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept